Shanghai Enlogics Biotechnology Co., Ltd. Established in September 2022 with a registered capital of RMB 18.254 million, the registered address is located in Lingang New Area of China (Shanghai) Pilot Free Trade Zone. Its predecessor was Zhejiang Lvchuang Biotechnology Co., Ltd., which was founded in 2015. It is a synthetic biology company dedicated to the research and production of green biological products.

The company has five subsidiaries, namely Shanghai Yinuoxin Biotechnology Co., Ltd., Zhejiang Lvchuang Biotechnology Co., Ltd., Anhui Yinuojike Biotechnology Co., Ltd., Youerke (Beijing) Biotechnology Co., Ltd., and Shanghai Yinuoyu Biotechnology Co., Ltd. They focus on research and development, pilot testing, production, and sales, and have established a new model of integrated operation of research, production, and sales.

Mr. Chu Xiaohe, the founder of the company, has been engaged in the development and management of synthetic biology related technologies for a long time. He has won multiple national scientific progress awards, enjoyed special government allowances, and successfully transformed multiple technologies to develop more than 20 new products for the market. Professor Ye Bangce, Chief Scientist, has been engaged in research in the fields of synthetic biology and bioengineering for a long time. He has won honors such as the Second Prize of Natural Science from the Ministry of Education, the Second Prize of Technical Invention from Shanghai, and the Meiji Dairy Life Science Award. More than 60% of the company's personnel have a bachelor's degree or above, with over 40 directly engaged in research and development work, demonstrating strong competitiveness in the field of synthetic biology.

The company always aims for "high-quality products, low prices, and honest services", focusing on the research and production of pure natural green biological products. The company's products cover natural flavors, chiral amino acids, dietary supplements, active ingredients for cosmetics, pharmaceutical intermediates, and more. For specific products, please refer to the product center on the official website, and we provide personalized product customization services for customers.

Since its establishment, the company has completed angel and pre-A rounds of financing, with a total amount of nearly 150 million RMB, fully demonstrating its enormous development potential and value. The company warmly welcomes all scholars to visit, guide, consult, and cooperate in the field of synthetic biology for common development.